Raymond James Financial Inc. Purchases 172,795 Shares of DENTSPLY SIRONA Inc. $XRAY

Key Points

• Raymond James Financial Inc. raised its stake in DENTSPLY SIRONA Inc. by 31.7%, acquiring an additional 172,795 shares and now holds approximately 0.36% of the company valued at $10.7 million.
• Multiple large investors have increased their positions in DENTSPLY SIRONA, with institutional ownership now at 95.70% of the company’s stock.
• Recent analyst reports have lowered price targets for DENTSPLY SIRONA, with an average rating of "Hold" and a target price of $18.64.

Raymond James Financial Inc. raised its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 31.7% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 717,301 shares of the medical instruments supplier's stock after purchasing an additional 172,795 shares during the period. Raymond James Financial Inc. owned approximately 0.36% of DENTSPLY SIRONA worth $10,716,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in DENTSPLY SIRONA by 2.8% in the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier's stock valued at $309,864,000 after purchasing an additional 557,329 shares in the last quarter. Lazard Asset Management LLC increased its position in shares of DENTSPLY SIRONA by 23.0% during the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock worth $152,678,000 after acquiring an additional 1,505,928 shares in the last quarter. Invenomic Capital Management LP increased its position in shares of DENTSPLY SIRONA by 201.0% during the fourth quarter. Invenomic Capital Management LP now owns 2,639,161 shares of the medical instruments supplier's stock worth $50,091,000 after acquiring an additional 1,762,428 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of DENTSPLY SIRONA by 0.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,108,014 shares of the medical instruments supplier's stock worth $31,494,000 after acquiring an additional 6,881 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of DENTSPLY SIRONA by 14.9% during the fourth quarter. Northern Trust Corp now owns 2,082,391 shares of the medical instruments supplier's stock worth $39,524,000 after acquiring an additional 269,502 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on XRAY. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Stifel Nicolaus lowered their price objective on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research report on Friday, August 8th. Wall Street Zen downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Finally, Wells Fargo & Company decreased their target price on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research report on Friday, August 8th. Two analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Stock Down 0.1%

DENTSPLY SIRONA stock opened at $14.30 on Friday. The company has a market cap of $2.85 billion, a P/E ratio of -3.02, a price-to-earnings-growth ratio of 0.89 and a beta of 0.94. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.48. The company has a fifty day simple moving average of $15.15 and a 200 day simple moving average of $15.35. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. The business had revenue of $936.00 million during the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm's revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a $0.16 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a yield of 4.5%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.